Buprenorphine. Kumar R, Saadabadi A. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017 Jun-. 2017 Oct 16. https://www.ncbi.nlm.nih.gov/books/NBK459126/

Camurus announces that FDA advisory committee recommends approval of CAM2038 for treatment of opioid use disorder Lund, Sweden. Camurus (NASDAQ STO: CAMX) today announced that the US Food and Drug Administration’s (FDA) Psychopharmacologic Dr…

USA/Buprenorphin. FDA Panel Backs New Drug for Opioid Use Disorder The US Food and Drug Administration's (FDA's) Psychopharmacologic Drugs Advisory Committee has voted 18 to 1 to recommend approval of an investigational drug for the treatment of op…

Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France Perrine Roux, Daniela Rojas Castro, Khadim Ndiaye…

Camurus: FDA stimmt für vorrangige Prüfung des NDA-Antrags für wöchentliche und monatliche CAM2038 Buprenorphin-Depots zur Behandlung von Opioidkonsumstörung Lund, Schweden (ots/PRNewswire) - FDA legt PDUFA-Entscheidungste…

Camurus announces European Medicines Agency validation of CAM2038 Marketing Authorization Application for treatment of opioid dependence Lund, Sweden — Camurus (NASDAQ STO: CAMX) today announced the company’s Marketing Authorization App…